Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

79.84
+1.101.40%
Post-market: 79.850.0100+0.01%19:59 EDT
Volume:18.47M
Turnover:1.45B
Market Cap:200.91B
PE:11.85
High:79.97
Open:78.28
Low:76.03
Close:78.74
Loading ...

Merck Price Target Maintained With a $115.00/Share by Guggenheim

Dow Jones
·
17 Apr

Leerink Partners Adjusts Price Target on Merck to $115 From $113, Keeps Outperform Rating

MT Newswires Live
·
17 Apr

Merck & Company (MRK) Receives a Buy from Guggenheim

TIPRANKS
·
17 Apr

Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks
·
17 Apr

Agilent Says Diagnostic Assay Gets European IVDR Certification in Gastric Cancer

MT Newswires Live
·
17 Apr

GRAPHIC-Take Five: Lasting damage

Reuters
·
17 Apr

Merck & Co. Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

Merck (NYSE:MRK) Secures Global Rights To Cyprumed's Oral Peptide Delivery Technology

Simply Wall St.
·
17 Apr

Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey
·
17 Apr

US STOCKS-Wall Street ends down slightly; tariff uncertainty keeps investors on edge

Reuters
·
16 Apr

US Begins Probes into Pharmaceutical, Chip Imports, Setting Stage for Tariffs

Reuters
·
15 Apr

Pharmaceutical Stocks Trim Their Gains. Trump Says Pharmaceutical Tariffs in Not Too Distant Future

Tiger Newspress
·
15 Apr

Merck to Integrate Medical Resources Into Microsoft's Health Care AI Platform

MT Newswires Live
·
14 Apr

ABBV vs. MRK: Which Drug Giant is a Better Buy Now?

Zacks
·
14 Apr

Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds?

Insider Monkey
·
14 Apr

Here's Why Summit Therapeutics Stock Soared 15% on Friday

Zacks
·
14 Apr

Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires?

Insider Monkey
·
14 Apr

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool
·
13 Apr

Nu, HPE, Merck, BMY, OXY: Trending by Analysts

TIPRANKS
·
12 Apr

The Chinese CEO Who Believes Her Cancer Drug Can Beat Merck's Bestseller -- WSJ

Dow Jones
·
12 Apr